A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers

Condition:   Advanced Malignancies Interventions:   Drug: AZD7648;   Drug: Pegylated liposomal doxorubicin (PLD);   Drug: Olaparib Sponsors:   AstraZeneca;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials